Quadrivalent HPV Vaccine and Targeted Ablation to Prevent Anal Condyloma, Dysplasia and Cancer
Stephen E. Goldstone, MD, FACS
Assistant Clinical Professor of Surgery
Icahn School of Medicine at Mount Sinai, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2013. All rights reserved.
At the completion of this educational session, learners will:
- Understand the long-term results of treating anal dysplasia.
- Understand the efficacy of quadrivalent HPV vaccine in preventing recurrent high-grade anal dysplasia.
- Understand the efficacy of quadrivalent HPV vaccine in preventing recurrent anal condyloma.
Dr. Stephen Goldstone is an Assistant Clinical Professor of Surgery at the Icahn School of Medicine at Mount Sinai, and has a surgical practice in New York City. He has developed surgical techniques to treat anal HPV dysplasia, is a member of the AIDS Malignancy Consortium, and is vice-president of the newly-formed International Anal Neoplasia Society (IANS). Dr. Goldstone is an expert on gay men’s health, anorectal disorders, and has done extensive research on human papillomavirus (HPV), including prevention and treatment procedures for HPV.
To obtain CME credit for this and other PRN programs, please visit the
PRN Video Channel at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
